NeuroBo Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q1 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
NeuroBo Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2017 to Q3 2024.
  • NeuroBo Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 284 %, a 25.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 284 -98.5 -25.8% Sep 30, 2024
Q2 2024 345 -13.6 -3.78% Jun 30, 2024
Q1 2024 440 +118 +36.5% Mar 31, 2024
Q4 2023 426 +27.3 +6.84% Dec 31, 2023
Q3 2023 382 -346 -47.5% Sep 30, 2023
Q2 2023 359 -344 -48.9% Jun 30, 2023
Q1 2023 322 -392 -54.9% Mar 31, 2023
Q4 2022 399 -390 -49.4% Dec 31, 2022
Q3 2022 728 +173 +31.1% Sep 30, 2022
Q2 2022 702 +194 +38.2% Jun 30, 2022
Q1 2022 715 +252 +54.4% Mar 31, 2022
Q4 2021 789 +435 +123% Dec 31, 2021
Q3 2021 555 +129 +30.2% Sep 30, 2021
Q2 2021 508 +153 +43% Jun 30, 2021
Q1 2021 463 +176 +61.1% Mar 31, 2021
Q4 2020 354 +59.2 +20.1% Dec 31, 2020
Q3 2020 427 +200 +88.7% Sep 30, 2020
Q2 2020 355 +21.1 +6.33% Jun 30, 2020
Q1 2020 287 -116 -28.7% Mar 31, 2020
Q4 2019 294 -160 -35.2% Dec 31, 2019
Q3 2019 226 -180 -44.3% Sep 30, 2019
Q2 2019 334 -98.4 -22.7% Jun 30, 2019
Q1 2019 403 -22.1 -5.2% Mar 31, 2019
Q4 2018 454 +18.8 +4.33% Dec 31, 2018
Q3 2018 406 -107 -20.8% Sep 30, 2018
Q2 2018 433 -238 -35.5% Jun 30, 2018
Q1 2018 425 +65 +18% Mar 31, 2018
Q4 2017 436 Dec 31, 2017
Q3 2017 513 Sep 30, 2017
Q2 2017 671 Jun 30, 2017
Q1 2017 360 Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.